表紙
市場調查報告書

原位雜合反應 (ISH) 市場全球市場 - 至2025年的預測:消耗品 (套件,探針),軟體

In Situ Hybridization (ISH) Market by Product (Consumables (Kits, Probes) Software), Technology (FISH (DNA, RNA), CISH), Application (Cancer, Infectious Disease), & End User (Diagnostic Labs, Research Institutes, CROs), Region-Global Forecast to 2025

出版商 MarketsandMarkets 商品編碼 955047
出版日期 內容資訊 英文 162 Pages
訂單完成後即時交付
價格
原位雜合反應 (ISH) 市場全球市場 - 至2025年的預測:消耗品 (套件,探針),軟體 In Situ Hybridization (ISH) Market by Product (Consumables (Kits, Probes) Software), Technology (FISH (DNA, RNA), CISH), Application (Cancer, Infectious Disease), & End User (Diagnostic Labs, Research Institutes, CROs), Region-Global Forecast to 2025
出版日期: 2020年08月18日內容資訊: 英文 162 Pages
簡介

全球原位雜合反應 (ISH)的市場規模,從2020年的9億美元,擴大到2025年到13億美元,在預測期間內預計以7.4%的年複合成長率成長。癌症的發生率增加和搭配診斷檢驗的認識,是推動市場成長的主要要素。但,熟練的人力資源不足,成為ISH市場的課題。

本報告提供全球原位雜合反應 (ISH) 市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 原位雜合反應 (ISH) 市場概要
  • 亞太地區 - :原位雜合反應 (ISH) 市場佔有率:各終端用戶,各國
  • 原位雜合反應 (ISH) 市場:各產品
  • 原位雜合反應 (ISH) 市場:各技術
  • 原位雜合反應 (ISH) 市場:各類型

第5章 市場概要

  • 市場動態
    • 推動市場要素
    • 機會
    • 課題
  • 價值鏈分析
  • COVID-19大爆發對原位雜合反應 (ISH) 市場成長的影響

第6章 原位雜合反應 (ISH) 市場:各產品

  • 消耗品
  • 設備
  • 軟體

第7章 原位雜合反應 (ISH) 市場:各技術

  • FISH
  • CISH

第8章 原位雜合反應 (ISH) 市場:各用途

  • 癌症診斷
  • 細胞學
  • 感染疾病診斷
  • 神經科學
  • 免疫學

第9章 原位雜合反應 (ISH) 市場:各終端用戶

  • 醫院、臨床檢驗室
  • 學術、研究機關
  • 製藥、生物科技企業
  • CRO

第10章 原位雜合反應 (ISH) 市場:各地區

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 其他的歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他的亞太地區
  • 其他地區
    • 南美
    • 中東、非洲

第11章 競爭情形

  • 市場排行榜分析
  • 市場評估組成架構
  • 競爭模式

第12章 企業評估矩陣和企業簡介

  • 概要
  • 企業評估矩陣
  • 企業簡介
    • ABBOTT LABORATORIES
    • F. HOFFMANN-LA ROCHE
    • AGILENT TECHNOLOGIES
    • THERMO FISHER SCIENTIFIC
    • BIO-TECHNE CORPORATION
    • QIAGEN NV
    • DANAHER CORPORATION
    • PERKINELMER
    • ENZO BIOCHEM
    • BIO-RAD LABORATORIES
    • MERCK KGAA
    • ABNOVA CORPORATION
    • BIOGENEX LABORATORIES
    • BIOCARE MEDICAL
    • OPGEN
    • BIO SB
    • GENEMED BIOTECHNOLOGIES
    • ABCAM
    • CREATIVE BIOARRAY
    • BIOCAT GMBH
    • ZYTOVISION

第13章 附錄

目錄
Product Code: BT 3649

"Increasing incidence of genetic disorders and ISH based companion diagnostics tests are set to drive the ISH market."

The global in situ hybridization (ISH) market size is projected to reach USD 1.3 billion by 2025 from USD 0.9 billion in 2020, at a CAGR of 7.4% during the forecast period. The increasing incidence of cancer and awareness of companion diagnostics test are the major factors driving the growth of this market. However, the lack of skilled professionals poses a challenge to ISH market.

"By consumables type, the kits & reagents accounted for the fastest-growing segment of the ISH market."

The kits & reagents segment accounted for the largest share of this market in 2019. The rise in government and private funding in life sciences and cancer research, the increasing number of reagent rental agreements, and the application of innovative technologies and methodologies in the fields of tissue and in vitro diagnostics are expected to drive the growth of the ISH consumables market during the forecast period.

"By technology type, the FISH segment accounted for the largest share of the ISH market."

Based on technology, the ISH market is segmented broadly into fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH). This segment accounted for the largest share of the global ISH market in 2019. The large share of this segment is attributed to the increasing demand for FISH kits and assays in CDx for cancer diagnostics, chromosomal abnormalities, and infectious diseases.

"Asia Pacific: The fastest-growing region in the ISH market."

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, The economic growth in the countries of this region, its large population base, the rising prevalence of chronic diseases, improvements in the standard of living, growing demand for quality medical care, increasing healthcare spending, government initiatives, and awareness regarding the use of tissue diagnostic tests (including ISH) are the major factors driving market growth in the APAC

"North America: the largest share of the ISH market."

North America accounted for the largest share of the ISH market. The large share of this segment can primarily be attributed to the presence of major players operating in the ISH market in the US, rising incidence of cancer and infectious diseases, and the increasing adoption of companion diagnostic assay kits.

Breakdown of Primaries:

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs.

The break-up of the primaries is as follows:

  • By Respondent - Supply Side- 80%, Demand Side-20%
  • By Designation - Executives- 25%, CXOs- 20%, Managers - 55%
  • By Region - North America - 50%, Europe - 20%, APAC - 20%, RoW- 10%

The ISH market is dominated by a few globally established players such as Abbott Laboratories(US), F. Hoffmann-La Roche (Switzerland), Agilent Technologies (US), Danaher Corporation (US), and Thermo Fisher Scientific (US), Abnova Corporation (Taiwan), BioGenex Laboratories (US), Genemed Biotechnologies (US), Bio-techne Corporation (US), Biocare Medical (US), and Bio SB (US), Bio-Rad Laboratories (US), Abcam (UK), PerkinElmer (US), QIAGEN N.V (Netherlands), and Merck KGaA (Germany), OpGen (US), Creative Bioarray (US), ZytoVision (Germany), BioCat GmbH (Germany), and Enzo Biochem (US).

Research Coverage:

The report segments the ISH market based on region (North America, Asia Pacific, Europe, and RoW), product (consumables, instruments, and software), application (Cancer diagnostics, cytology, infectious disease diagnostics, neuroscience, and immunology), and end-user (hospitals & diagnostic laboratories, academic & research institutes, pharmaceutical & biotechnology companies, and CROs).

The report also provides a comprehensive review of market drivers, challenges, and opportunities in the ISH market.

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the ISH market and provides them information on key market drivers, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 1 BREAKDOWN OF PRIMARIES: IN SITU HYBRIDIZATION MARKET
  • 2.2 MARKET DATA ESTIMATION & TRIANGULATION
    • FIGURE 2 DATA TRIANGULATION METHODOLOGY
  • 2.3 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 MARKET SIZE ESTIMATION (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)
    • FIGURE 4 IN SITU HYBRIDIZATION MARKET SIZE (USD MILLION)
    • FIGURE 5 IN SITU HYBRIDIZATION MARKET: FINAL CAGR PROJECTIONS (2020-2025)
    • FIGURE 6 IN SITU HYBRIDIZATION MARKET: CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS AND OPPORTUNITIES
  • 2.4 INDUSTRY INSIGHTS
  • 2.5 RESEARCH ASSUMPTIONS

3 EXECUTIVE SUMMARY

    • FIGURE 7 IN SITU HYBRIDIZATION MARKET SHARE, BY PRODUCT, 2019
    • FIGURE 8 FLUORESCENCE IN SITU HYBRIDIZATION MARKET SHARE, BY TYPE, 2019
    • FIGURE 9 IN SITU HYBRIDIZATION MARKET, BY END USER: MARKET RANKING OF SEGMENTS, BY MARKET SIZE
    • FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE IN SITU HYBRIDIZATION MARKET

4 PREMIUM INSIGHTS

  • 4.1 IN SITU HYBRIDIZATION MARKET OVERVIEW
    • FIGURE 11 RISING FOCUS ON COMPANION DIAGNOSTICS AND INCREASING DISEASE INCIDENCE WILL FAVOR MARKET GROWTH
  • 4.2 ASIA PACIFIC: IN SITU HYBRIDIZATION MARKET SHARE, BY END USER AND COUNTRY (2019)
    • FIGURE 12 HOSPITAL & DIAGNOSTIC LABORATORIES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2019
  • 4.3 IN SITU HYBRIDIZATION MARKET, BY PRODUCT
    • FIGURE 13 CONSUMABLES SEGMENT WILL CONTINUE TO DOMINATE THE MARKET
  • 4.4 IN SITU HYBRIDIZATION MARKET SHARE, BY TECHNOLOGY, 2020 VS. 2025
    • FIGURE 14 FLUORESCENCE IN SITU HYBRIDIZATION HOLDS THE LARGEST SHARE OF THE MARKET, BY TECHNOLOGY
  • 4.5 IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 15 KITS & REAGENTS SEGMENT ACCOUNT FOR THE LARGEST MARKET SHARE

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 16 IN SITU HYBRIDIZATION MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 MARKET DRIVERS
      • 5.2.1.1 Increasing incidence of genetic disorders and cancer
      • 5.2.1.2 Awareness about companion diagnostics
    • 5.2.2 OPPORTUNITIES
      • 5.2.2.1 Untapped markets in developing countries
    • 5.2.3 CHALLENGES
      • 5.2.3.1 Lack of skilled professionals
  • 5.3 VALUE CHAIN ANALYSIS
    • FIGURE 17 VALUE CHAIN ANALYSIS OF THE IN SITU HYBRIDIZATION MARKET: RAW MATERIAL AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE
  • 5.4 IMPACT OF THE COVID-19 OUTBREAK ON THE GROWTH OF THE IN SITU HYBRIDIZATION MARKET

6 IN SITU HYBRIDIZATION MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 1 IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • 6.2 CONSUMABLES
    • TABLE 2 IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 3 IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 4 NORTH AMERICA: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 5 EUROPE: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 6 APAC: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 6.2.1 KITS & REAGENTS
      • 6.2.1.1 Increasing focus on companion diagnostics has driven market demand for kits & reagents
    • TABLE 7 IN SITU HYBRIDIZATION KITS & REAGENTS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 6.2.2 PROBES
      • 6.2.2.1 Preference for direct localization of DNA/RNA sequences using probes is likely to drive the market
    • TABLE 8 IN SITU HYBRIDIZATION PROBES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 6.2.3 ACCESSORIES
    • TABLE 9 IN SITU HYBRIDIZATION ACCESSORIES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 6.3 INSTRUMENTS
    • 6.3.1 NEED FOR AUTOMATED SYSTEMS SUPPORTS MARKET GROWTH
    • TABLE 10 IN SITU HYBRIDIZATION INSTRUMENTS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 11 NORTH AMERICA: IN SITU HYBRIDIZATION INSTRUMENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 12 EUROPE: IN SITU HYBRIDIZATION INSTRUMENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 13 APAC: IN SITU HYBRIDIZATION INSTRUMENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 6.4 SOFTWARE
    • 6.4.1 DEMAND FOR SOFTWARE IS DRIVEN BY THE NEED FOR HIGH-SPEED SAMPLE DATA ANALYSIS
    • TABLE 14 IN SITU HYBRIDIZATION SOFTWARE MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 15 NORTH AMERICA: IN SITU HYBRIDIZATION SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 16 EUROPE: IN SITU HYBRIDIZATION SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 17 APAC: IN SITU HYBRIDIZATION SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION)

7 IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
    • TABLE 18 IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • 7.2 FLUORESCENCE IN SITU HYBRIDIZATION
    • TABLE 19 FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 20 FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 21 NORTH AMERICA: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 22 EUROPE: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 23 APAC: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.2.1 DNA FLUORESCENCE IN SITU HYBRIDIZATION
      • 7.2.1.1 Need to ensure the stability of genetic material likely to drive the market
    • TABLE 24 DNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 25 NORTH AMERICA: DNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 26 EUROPE: DNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 27 APAC: DNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.2.2 RNA FLUORESCENCE IN SITU HYBRIDIZATION
      • 7.2.2.1 Rise in biomedical research activity has supported market growth
    • TABLE 28 RNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 29 NORTH AMERICA: RNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 30 EUROPE: RNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 31 APAC: RNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.2.3 PNA FLUORESCENCE IN SITU HYBRIDIZATION
      • 7.2.3.1 Increased application in infectious disease resulted in market growth
    • TABLE 32 PNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 33 NORTH AMERICA: PNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 34 EUROPE: PNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 35 APAC: PNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 7.3 CHROMOGENIC IN SITU HYBRIDIZATION
    • 7.3.1 COST-EFFECTIVENESS OVER FLUORESCENCE IN SITU HYBRIDIZATION FISH SUPPORTS MARKET GROWTH
    • TABLE 36 CHROMOGENIC IN SITU HYBRIDIZATION MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 37 NORTH AMERICA: CHROMOGENIC IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 38 EUROPE: CHROMOGENIC IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 39 APAC: CHROMOGENIC IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)

8 IN SITU HYBRIDIZATION MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 40 IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • 8.2 CANCER DIAGNOSTICS
    • 8.2.1 INCREASING IMPORTANCE IN COMPANION DIAGNOSTICS TO DRIVE MARKET GROWTH
    • TABLE 41 IN SITU HYBRIDIZATION MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 42 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 43 EUROPE: IN SITU HYBRIDIZATION MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 44 APAC: IN SITU HYBRIDIZATION MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2018-2025 (USD MILLION)
  • 8.3 CYTOLOGY
    • 8.3.1 FISH IS PREFERRED IN THE DETECTION OF CHROMOSOMAL ABNORMALITIES
    • TABLE 45 IN SITU HYBRIDIZATION MARKET FOR CYTOLOGY, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 46 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET FOR CYTOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 47 EUROPE: IN SITU HYBRIDIZATION MARKET FOR CYTOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 48 APAC: IN SITU HYBRIDIZATION MARKET FOR CYTOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
  • 8.4 INFECTIOUS DISEASE DIAGNOSTICS
    • 8.4.1 NEED FOR HIGH SENSITIVITY AND SPECIFICITY IN INFECTIOUS DIAGNOSIS IS LIKELY TO SUPPORT MARKET GROWTH
    • TABLE 49 IN SITU HYBRIDIZATION MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 50 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 51 EUROPE: IN SITU HYBRIDIZATION MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 52 APAC: IN SITU HYBRIDIZATION MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2025 (USD MILLION)
  • 8.5 NEUROSCIENCE
    • 8.5.1 RISING BURDEN OF NEUROLOGICAL DISORDERS HAS BOOSTED OVERALL R&D ACTIVITY
    • TABLE 53 IN SITU HYBRIDIZATION MARKET FOR NEUROSCIENCE, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 54 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET FOR NEUROSCIENCE, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 55 EUROPE: IN SITU HYBRIDIZATION MARKET FOR NEUROSCIENCE, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 56 APAC: IN SITU HYBRIDIZATION MARKET FOR NEUROSCIENCE, BY COUNTRY, 2018-2025 (USD MILLION)
  • 8.6 IMMUNOLOGY
    • 8.6.1 RISING INCIDENCE OF AUTOIMMUNE DISEASES SUPPORTS MARKET GROWTH
    • TABLE 57 IN SITU HYBRIDIZATION MARKET FOR IMMUNOLOGY, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 58 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET FOR IMMUNOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 59 EUROPE: IN SITU HYBRIDIZATION MARKET FOR IMMUNOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 60 APAC: IN SITU HYBRIDIZATION MARKET FOR IMMUNOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)

9 IN SITU HYBRIDIZATION MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 61 IN SITU HYBRIDIZATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.2 HOSPITAL & DIAGNOSTIC LABORATORIES
    • 9.2.1 DEMAND FOR MOLECULAR TESTS TO DRIVE MARKET GROWTH
    • TABLE 62 IN SITU HYBRIDIZATION MARKET FOR HOSPITAL & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 63 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET FOR HOSPITAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 64 EUROPE: IN SITU HYBRIDIZATION MARKET FOR HOSPITAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 65 APAC: IN SITU HYBRIDIZATION MARKET FOR HOSPITAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • 9.3 ACADEMIC & RESEARCH INSTITUTES
    • 9.3.1 INCREASING RESEARCH ON CHROMOSOMAL ABNORMALITIES WILL SUPPORT MARKET GROWTH
    • TABLE 66 IN SITU HYBRIDIZATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 67 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 68 EUROPE: IN SITU HYBRIDIZATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 69 APAC: IN SITU HYBRIDIZATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
  • 9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.4.1 NEED TO DEVELOP PRECISION TREATMENTS DRIVES DEMAND FOR IN SITU HYBRIDIZATION
    • TABLE 70 IN SITU HYBRIDIZATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 71 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 72 EUROPE: IN SITU HYBRIDIZATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 73 APAC: IN SITU HYBRIDIZATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • 9.5 CONTRACT RESEARCH ORGANIZATIONS
    • 9.5.1 INCREASING OUTSOURCING OF RESEARCH ACTIVITIES TO SUPPORT MARKET GROWTH
    • TABLE 74 IN SITU HYBRIDIZATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 75 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 76 EUROPE: IN SITU HYBRIDIZATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 77 APAC: IN SITU HYBRIDIZATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2025 (USD MILLION)

10 IN SITU HYBRIDIZATION MARKET, BY REGION

  • 10.1 INTRODUCTION
    • FIGURE 18 IN SITU HYBRIDIZATION MARKET SNAPSHOT
    • TABLE 78 IN SITU HYBRIDIZATION MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 19 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET SNAPSHOT
    • TABLE 79 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 80 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 81 NORTH AMERICA: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 82 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 83 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 84 NORTH AMERICA: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018-2025(USD MILLION)
    • TABLE 85 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 Government funding for life science research drives the market growth in the US
    • TABLE 86 US: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 87 US: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 88 US: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 89 US: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 90 US: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 91 US: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Investments by the Canadian government and non-profit organizations for innovation are likely to boost the market
    • TABLE 92 CANADA: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 93 CANADA: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 94 CANADA: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 95 CANADA: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 96 CANADA: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 97 CANADA: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 98 EUROPE: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 99 EUROPE: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 100 EUROPE: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 101 EUROPE: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 102 EUROPE: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 103 EUROPE: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 104 EUROPE: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Germany accounted for the largest share of the European market
    • TABLE 105 GERMANY: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 106 GERMANY: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 107 GERMANY: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 108 GERMANY: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 109 GERMANY: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 110 GERMANY: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 10.3.2 FRANCE
      • 10.3.2.1 Increased investments in proteomics and genomics are likely to fuel the growth of ISH technology
    • TABLE 111 FRANCE: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 112 FRANCE: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 113 FRANCE: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 114 FRANCE: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 115 FRANCE: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 116 FRANCE: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 10.3.3 UK
      • 10.3.3.1 Increasing focus on cancer research in the UK is a key market growth driver
    • TABLE 117 UK: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 118 UK: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 119 UK: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 120 UK: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 121 UK: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 122 UK: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 10.3.4 REST OF EUROPE
    • TABLE 123 ROE: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 124 ROE: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 125 ROE: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 126 ROE: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 127 ROE: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 128 ROE: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 20 ASIA PACIFIC: IN SITU HYBRIDIZATION MARKET SNAPSHOT
    • TABLE 129 APAC: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 130 APAC: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 131 APAC: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 132 APAC: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 133 APAC: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 134 APAC: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 135 APAC: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Focus on personalized diagnostics products to support market growth in Japan
    • TABLE 136 JAPAN: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 137 JAPAN: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 138 JAPAN: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 139 JAPAN: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 140 JAPAN: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 141 JAPAN: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 China forms the fastest-growing market in the APAC
    • TABLE 142 CHINA: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 143 CHINA: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 144 CHINA: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 145 CHINA: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 146 CHINA: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 147 CHINA: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Collaborations between hospitals and diagnostics labs will propel market growth in India
    • TABLE 148 INDIA: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 149 INDIA: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 150 INDIA: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 151 INDIA: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 152 INDIA: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 153 INDIA: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 10.4.4 REST OF ASIA PACIFIC
    • TABLE 154 ROAPAC: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 155 ROAPAC: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 156 ROAPAC: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 157 ROAPAC: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 158 ROAPAC: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 159 ROAPAC: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • 10.5 REST OF THE WORLD
    • TABLE 160 ROW: IN SITU HYBRIDIZATION MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 161 ROW: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 162 ROW: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 163 ROW: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 164 ROW: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 165 ROW: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 166 ROW: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 10.5.1 LATIN AMERICA
      • 10.5.1.1 Growing cancer screening programs will propel market growth in Latin America
    • TABLE 167 LATAM: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 168 LATAM: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 169 LATAM: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 170 LATAM: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 171 LATAM: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 172 LATAM: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 10.5.2 MIDDLE EAST & AFRICA
      • 10.5.2.1 Infrastructural development is expected to contribute to the growth of the MEA market
    • TABLE 173 MEA: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 174 MEA: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 175 MEA: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 176 MEA: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 177 MEA: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 178 MEA: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 MARKET RANKING ANALYSIS
    • FIGURE 21 COMPANY RANKING IN THE IN SITU HYBRIDIZATION MARKET, 2019
  • 11.3 MARKET EVALUATION FRAMEWORK
    • TABLE 179 MARKET EVALUATION FRAMEWORK: AGREEMENT & PRODUCT LAUNCH- THE MAJOR STRATEGY ADOPTED BY PLAYERS
  • 11.4 COMPETITIVE SCENARIO
    • 11.4.1 KEY PRODUCT LAUNCHES
    • 11.4.2 KEY COLLABORATIONS & AGREEMENTS
    • 11.4.3 KEY EXPANSIONS

12 COMPANY EVALUATION MATRIX AND COMPANY PROFILES

  • 12.1 OVERVIEW
  • 12.2 IN SITU HYBRIDIZATION MARKET: COMPANY EVALUATION MATRIX
    • 12.2.1 STARS
    • 12.2.2 EMERGING LEADERS
    • 12.2.3 PERVASIVE COMPANIES
    • 12.2.4 EMERGING COMPANIES
    • FIGURE 22 GLOBAL IN SITU HYBRIDIZATION MARKET: COMPANY EVALUATION MATRIX, 2019
  • 12.3 COMPANY PROFILES
    • 12.3.1 ABBOTT LABORATORIES
    • FIGURE 23 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
    • 12.3.2 F. HOFFMANN-LA ROCHE
    • FIGURE 24 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2019)
    • 12.3.3 AGILENT TECHNOLOGIES
    • FIGURE 25 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019)
    • 12.3.4 THERMO FISHER SCIENTIFIC
    • FIGURE 26 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
    • 12.3.5 BIO-TECHNE CORPORATION
    • FIGURE 27 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2019)
    • 12.3.6 QIAGEN N.V.
    • FIGURE 28 QIAGEN N.V.: COMPANY SNAPSHOT (2019)
    • 12.3.7 DANAHER CORPORATION
    • FIGURE 29 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
    • 12.3.8 PERKINELMER
    • FIGURE 30 PERKINELMER: COMPANY SNAPSHOT (2019)
    • 12.3.9 ENZO BIOCHEM
    • FIGURE 31 ENZO BIOCHEM: COMPANY SNAPSHOT (2019)
    • 12.3.10 BIO-RAD LABORATORIES
    • FIGURE 32 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019)
    • 12.3.11 MERCK KGAA
    • FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2019)
    • 12.3.12 ABNOVA CORPORATION
    • 12.3.13 BIOGENEX LABORATORIES
    • 12.3.14 BIOCARE MEDICAL
    • 12.3.15 OPGEN
    • FIGURE 34 OPGEN: COMPANY SNAPSHOT (2019)
    • 12.3.16 BIO SB
    • 12.3.17 GENEMED BIOTECHNOLOGIES
    • 12.3.18 ABCAM
    • FIGURE 35 ABCAM: COMPANY SNAPSHOT (2019)
    • 12.3.19 CREATIVE BIOARRAY
    • 12.3.20 BIOCAT GMBH
    • 12.3.21 ZYTOVISION

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS